TABLE 1.
Demographic and Risk Characteristics of Persons Diagnosed With AIDS Before and After the Introduction of Highly Active Antiretroviral Therapy: Chicago, 1993–2001
| Characteristic | Pre-HAART Era, 1993–1995, No. (%) | HAART Era, 1996–2001, No. (%) | Total, No. (%) |
| Gender | |||
| Male | 4 353 (83.5) | 4 514 (77.8) | 8 867 (80.5) |
| Female | 863 (16.6) | 1 292 (22.3) | 2 155 (19.6) |
| Race/Ethnicity | |||
| Non-Hispanic Black | 2 966 (56.9) | 3 858 (66.5) | 6 824 (61.9) |
| Non-Hispanic White | 1 527 (29.3) | 1 102 (19) | 2 629 (23.9) |
| Hispanic | 723 (13.9) | 846 (14.6) | 1 569 (14.2) |
| Mode of transmission | |||
| Male-to-male sexual contact | 2 524 (51.1) | 2 250 (42.8) | 4 774 (46.8) |
| Injection drug use | 2 040 (41.3) | 2 218 (42.2) | 4 258 (41.8) |
| Heterosexual contact | 376 ( 7.6) | 790 (15) | 1 166 (11.4) |
| Age at diagnosis, y | |||
| 13–29 | 735 (14.3) | 736 (12.8) | 1 471 (13.5) |
| 30–49 | 3 849 (74.5) | 4 248 (73.6) | 8 097 (74.1) |
| ≥ 50 | 573 (11.1) | 788 (13.7) | 1 361 (12.5) |
| Opportunistic diseases | |||
| Pneumocystis carinii pneumonia | 489 (9.4) | 469 ( 8.1) | 958 (8.7) |
| Kaposi's sarcoma | 88 (1.7) | 67 ( 1.2) | 155 (1.4) |
| Othera | 2 865 (54.9) | 2 496 (43.8) | 5 361 (48.6) |
| No disease specified | 1 774 (34) | 2 774 (47.8) | 4 548 (41.3) |
| Vital status | |||
| Alive | 1 681 (32.2) | 3 628 (62.5) | 5 309 (48.2) |
| Deceased | 3 535 (67.8) | 2 178 (37.5) | 5 731 (51.2) |
| Deaths from AIDS | 2 159 (41.4) | 1 157 (19.9) | 3 316 (30.1) |
| Deaths from other causes | 1 376 (26.4) | 1 021 (17.6) | 2 397 (21.8) |
| Total | 5 216 (47.3) | 5 806 (52.7) | 11 022 (100) |
Note. HAART = highly active antiretroviral therapy.
a
All diseases except Pneumocystis carinii pneumonia and Kaposi's sarcoma.